| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hei-Jen Jou, I-Ping Hsu, Pei-Ying Ling, Chia-Tzu Lin, Suei-Tsau Tsai, Hui-Ting Huang, Shiao-Chi W. Hip circumference is an important predictor of plasma C-reactive protein levels in overweight and obese Taiwanese women. Taiwanese journal of obstetrics & gynecology. vol 45. issue 3. 2007-01-09. PMID:17175466. |
to investigate the relationship between serum levels of c-reactive protein (crp) with obesity, insulin resistance and metabolic syndrome in overweight or obese taiwanese women. |
2007-01-09 |
2023-08-12 |
Not clear |
| Christian K Roberts, Dean Won, Sandeep Pruthi, San San Lin, R James Barnar. Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men. Diabetes research and clinical practice. vol 73. issue 3. 2007-01-08. PMID:16616795. |
in each subject, pre- and post-intervention fasting blood was drawn for circulating levels of serum lipids, glucose and insulin, oxidative stress marker 8-isoprostaglandin f2alpha (8-iso-pgf2alpha), the inflammatory protein c-reactive protein (crp), and soluble intracellular adhesion molecule (sicam)-1 and se-selectin as indicators of endothelial activation. |
2007-01-08 |
2023-08-12 |
human |
| Christian K Roberts, Dean Won, Sandeep Pruthi, San San Lin, R James Barnar. Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men. Diabetes research and clinical practice. vol 73. issue 3. 2007-01-08. PMID:16616795. |
after 3 weeks, significant reductions (p<0.05) in bmi, all serum lipids including total cholesterol (pre: 188.9+/-10.1 mg/dl versus post: 146.3+/-3.8 mg/dl) and low-density lipoprotein (103.1+/-10.2 mg/dl versus 76.4+/-4.3 mg/dl), fasting serum glucose (157.5+/-10.1 mg/dl versus 126.7+/-8.7 mg/dl), insulin (33.8+/-4.0 microu/ml versus 23.8+/-3.4 microu/ml), homeostasis model assessment for insulin resistance, 8-iso-pgf2alpha, crp, sicam-1, and se-selectin were noted. |
2007-01-08 |
2023-08-12 |
human |
| T Fulop, D Tessier, A Carpentie. The metabolic syndrome. Pathologie-biologie. vol 54. issue 7. 2007-01-04. PMID:16904849. |
this inflammation, via the generated pro-inflammatory molecules, interferes with the normal insulin signalling and thus contributes to the etiopathogenesis of the ms. large clinical studies showed that crp is increased in obese subjects and concomitantly to the number of existing component of the ms. |
2007-01-04 |
2023-08-12 |
human |
| Jamal Ahmad, Faiz Ahmed, Mohammad A Siddiqui, Basharat Hameed, Ibne Ahma. Inflammation, insulin resistance and carotid IMT in first degree relatives of north Indian type 2 diabetic subjects. Diabetes research and clinical practice. vol 73. issue 2. 2007-01-03. PMID:16530289. |
plasma glucose, insulin (fasting and 2h after 75gm oral glucose) lipids and serum levels of c-reactive protein (crp), tumour necrosis factor (tnf)-alpha and fibrinogen were measured after an overnight fast of 10-12h. |
2007-01-03 |
2023-08-12 |
human |
| Subhashini Yaturu, Robert P Daberry, Justin Rains, Sushil Jai. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. Cytokine. vol 34. issue 3-4. 2006-12-21. PMID:16822679. |
in a cross-sectional study, we measured glucose, fasting lipid panel, resistin, adiponectin, insulin, c-reactive protein (crp) and tnf-alpha in 57 subjects with cad, 58 subjects with diabetes compared to 45 normal control subjects. |
2006-12-21 |
2023-08-12 |
human |
| Guoyue Yuan, Libin Zhou, Jinfeng Tang, Ying Yang, Weiqiong Gu, Fengying Li, Jie Hong, Yanyun Gu, Xiaoying Li, Guang Ning, Mingdao Che. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes research and clinical practice. vol 72. issue 3. 2006-12-01. PMID:16377022. |
serum crp levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. |
2006-12-01 |
2023-08-12 |
human |
| Flavio Nervi, Juan Francisco Miquel, Manuel Alvarez, Catterina Ferreccio, María José García-Zattera, Robinson González, Rosa María Pérez-Ayuso, Attilio Rigotti, Luís Villarroe. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. Journal of hepatology. vol 45. issue 2. 2006-11-28. PMID:16516330. |
we tested whether cholesterol gallstone disease (gs) is associated to insulin resistance and serum c-reactive protein (crp) in a high risk population. |
2006-11-28 |
2023-08-12 |
Not clear |
| Tzung-Dau Wang, Wen-Jone Chen, Wern-Cherng Cheng, Jong-Wei Lin, Ming-Fong Chen, Yuan-Teh Le. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. The American journal of cardiology. vol 98. issue 8. 2006-11-24. PMID:17027571. |
we examined the effects of rosiglitazone on the plasma markers of metabolic control (glucose, insulin, adiponectin, resistin, and lipid profiles), markers of inflammation (high-sensitivity c-reactive protein [crp], interleukin-6, soluble cd40 ligand, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1), and markers of vasoreactivity (asymmetric dimethylarginine [adma] and endothelin-1) and analyzed the relations between changes in endothelium-dependent flow-mediated dilation of the brachial artery and changes in these markers to elucidate their roles in mediating the vascular protective effects of rosiglitazone. |
2006-11-24 |
2023-08-12 |
Not clear |
| Tzung-Dau Wang, Wen-Jone Chen, Wern-Cherng Cheng, Jong-Wei Lin, Ming-Fong Chen, Yuan-Teh Le. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. The American journal of cardiology. vol 98. issue 8. 2006-11-24. PMID:17027571. |
at study end, treatment with rosiglitazone had significantly reduced plasma insulin (-25%, p = 0.004) and resistin (-16%, p <0.001), increased adiponectin (164%, p <0.001), low-density lipoprotein cholesterol (16%, p = 0.005), and apolipoprotein-b (14%, p = 0.003), and decreased crp (-30%, p = 0.005), soluble cd40 ligand (-20%, p = 0.014), adma (-16%, p <0.001), and endothelin-1 (-11%, p <0.001) concentrations and systolic and diastolic blood pressures. |
2006-11-24 |
2023-08-12 |
Not clear |
| Kailash Prasa. C-reactive protein (CRP)-lowering agents. Cardiovascular drug reviews. vol 24. issue 1. 2006-11-21. PMID:16939632. |
antidiabetic agents (rosiglitazone and pioglitazone) reduce crp levels, while insulin is ineffective. |
2006-11-21 |
2023-08-12 |
Not clear |
| Yaprak Engin-Ustün, Yusuf Ustün, M Mutlu Meydanli, Ayşe Kafkasli, Gülay Yetki. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome? Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. vol 22. issue 6. 2006-11-14. PMID:16785157. |
our aim was to assess c-reactive protein (crp) levels and insulin resistance in women with polycystic ovary syndrome (pcos) or polycystic ovaries (pco). |
2006-11-14 |
2023-08-12 |
Not clear |
| Gustavo Arturo Rodríguez-Leal, Segundo Morán, Irazu Gallardo, Pilar Milke, Luis Guevara-Gonzále. [Assessment of high sensitivity C-reactive protein (HS-CRP) as a marker of liver inflammation in patients with metabolic syndrome]. Revista de gastroenterologia de Mexico. vol 71. issue 1. 2006-11-14. PMID:17063573. |
c-reactive protein (crp) plays an important role on inflammatory processes associated to the metabolic syndrome (ms), alike of insulin sensitivity, endothelial dysfunction and fibrinolysis insufficiency. |
2006-11-14 |
2023-08-12 |
Not clear |
| Carmine Zoccali, Raffaele Maio, Francesca Mallamaci, Giorgio Sesti, Francesco Perticon. Uric acid and endothelial dysfunction in essential hypertension. Journal of the American Society of Nephrology : JASN. vol 17. issue 5. 2006-11-02. PMID:16611716. |
all patients underwent the following procedures: bp measurements, laboratory tests (c-reactive protein [crp], insulin resistance by homeostasis model assessment, serum creatinine, and ua), and endothelial function evaluated by intra-arterial infusion of acetylcholine (ach). |
2006-11-02 |
2023-08-12 |
Not clear |
| Anders Bojesen, Kurt Kristensen, Niels H Birkebaek, Jens Fedder, Leif Mosekilde, Paul Bennett, Peter Laurberg, Jan Frystyk, Allan Flyvbjerg, Jens S Christiansen, Claus H Gravhol. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes care. vol 29. issue 7. 2006-11-01. PMID:16801584. |
fasting blood samples were analyzed for sex hormones, plasma glucose, insulin, c-reactive protein (crp), and adipocytokines. |
2006-11-01 |
2023-08-12 |
human |
| Tomoyuki Iwasaki, Atsushi Nakajima, Masato Yoneda, Yasuo Terauch. Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus. Endocrine journal. vol 53. issue 3. 2006-10-20. PMID:16714840. |
in this study, we investigated the association between the serum crp concentrations and parameters of adiposity and insulin resistance in both japanese type 2 diabetes patients and non-diabetic subjects. |
2006-10-20 |
2023-08-12 |
human |
| Raj Deepa, Kaliyaperumal Velmurugan, Kannan Arvind, Pillarisetti Sivaram, Cahoon Sientay, Saxena Uday, Viswanathan Moha. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES). Metabolism: clinical and experimental. vol 55. issue 9. 2006-10-13. PMID:16919544. |
the aim of this cross-sectional study was to assess the association of insulin resistance (ir) with inflammatory molecules c-reactive protein (crp), interleukin 6 (il-6), vascular cell adhesion molecule 1 (vcam-1), and monocyte chemotactic protein 1 (mcp-1) in urban south indian subjects. |
2006-10-13 |
2023-08-12 |
human |
| Abel López-Bermejo, Javad Khosravi, José Manuel Fernández-Real, Vivian Hwa, Katherine L Pratt, Roser Casamitjana, Maria M Garcia-Gil, Ron G Rosenfeld, Wifredo Ricar. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). Diabetes. vol 55. issue 8. 2006-10-06. PMID:16873698. |
insulin sensitivity (insulin sensitivity index [s(i)] from intravenous glucose tolerance tests in nondiabetic subjects, or the rate constant for disappearance of glucose [k(itt)] from insulin tolerance tests in type 2 diabetic subjects), circulating igfbp-rp1 (from enzyme-linked immunosorbent assay), adiponectin (from radioimmunoassay), c-reactive protein (crp; from immunoturbidimetry), soluble tumor necrosis factor receptor 2 (stnfr2; from enzyme-amplified sensitivity immunoassay), and igf system parameters (igf-i, free igf-i, and igfbp-1 from immunoradiometric assay) were assessed in all subjects. |
2006-10-06 |
2023-08-12 |
human |
| Steven E Kahn, Bernard Zinman, Steven M Haffner, M Colleen O'Neill, Barbara G Kravitz, Dahong Yu, Martin I Freed, William H Herman, Rury R Holman, Nigel P Jones, John M Lachin, Giancarlo C Vibert. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes. vol 55. issue 8. 2006-10-06. PMID:16873701. |
further, for crp and fibrinogen this relationship is determined by body adiposity and not by insulin sensitivity or glucose control. |
2006-10-06 |
2023-08-12 |
human |
| Nita G Forouhi, Naveed Satta. CVD risk factors and ethnicity--a homogeneous relationship? Atherosclerosis. Supplements. vol 7. issue 1. 2006-09-28. PMID:16500156. |
ethnic groups show differences in levels of visceral adiposity, insulin resistance, and novel risk markers such as c-reactive protein (crp), adiponectin and plasma homocysteine. |
2006-09-28 |
2023-08-12 |
Not clear |